Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies
University of Pennsylvania · Children's Hospital of Philadelphia · +5 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
69
total citations
- FWCI
- 55.24
- Percentile
- 100%
- References
- 90
Citations per year
Authors
66Topics & keywords
Topics
Keywords
- Genetic enhancement
- Term (time)
- Coronavirus disease 2019 (COVID-19)
- Virology
- Medicine
- Gene
- Computational biology
- Biology
No related works found for this paper.